| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |